Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)
Arrotex Pharmaceuticals Pty Ltd
rizatriptan benzoate
Tablet, orally disintegrating
Excipient Ingredients: microcrystalline cellulose; magnesium stearate; mannitol; crospovidone; sucralose; Flavour
Oral
2
(S4) Prescription Only Medicine
Rizatriptan is indicated for the acute treatment of migraine attacks with or without aura.
Visual Identification: White to off-white coloured, round-shaped tablets with "APO" engraved on one side and "RZ" over "5" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2016-02-09